Incidence and prevalence support the need for routine screening

Worldwide, more than 500,000 new cases of cervical cancer are diagnosed annually and approximately 275,000 deaths occur each year.1

Cervical cancer disproportionately affects women who don’t have access to screening methods: more than 85% of newly diagnosed cases and nearly 90% of deaths are in underdeveloped countries.1

In developed regions of the world, death rates due to cervical cancer have been declining since the 1970s. Still, among women, cervical cancer remains the

  • Third most prevalent cancer
  • Fourth leading cause of cancer-related death2

Declining incidence and mortality in the United States

cervical_cancer_ declining_incidence_and_mortality

Source: SEER data (1992-2010).3

Explore current incidence and mortality rates of cervical cancer throughout the world

Key to preventing invasive cervical cancer is implementation of a screening program that enables the identification of women at high risk and intervention before disease becomes invasive.

Screening and prevention

The disparity in incidence and mortality rates between developed and developing countries is largely due to different levels of awareness and incidental screening, as well as the presence of routine screening programs, which are almost non-existent in many countries.2

New cases
(as of 2008)
(as of 2008)
Less developed regions 453,000 242,000
More developed regions 76,000 32,000
Source: GLOBOCAN 2008.1

In some developed nations, as many as half of all women diagnosed with invasive cervical cancer never had routine Pap screening and approximately 10% had not been tested for at least 5 years.4

Read about cervical cancer screening in Australia

Read about cervical cancer screening in England

Learn about current screening guidelines